139 related articles for article (PubMed ID: 26663089)
1. KPNA2 over-expression is a potential marker of prognosis and therapeutic sensitivity in colorectal cancer patients.
Takada T; Tsutsumi S; Takahashi R; Ohsone K; Tatsuki H; Suto T; Kato T; Fujii T; Yokobori T; Kuwano H
J Surg Oncol; 2016 Feb; 113(2):213-7. PubMed ID: 26663089
[TBL] [Abstract][Full Text] [Related]
2. Significance of karyopherin-{alpha} 2 (KPNA2) expression in esophageal squamous cell carcinoma.
Sakai M; Sohda M; Miyazaki T; Suzuki S; Sano A; Tanaka N; Inose T; Nakajima M; Kato H; Kuwano H
Anticancer Res; 2010 Mar; 30(3):851-6. PubMed ID: 20393006
[TBL] [Abstract][Full Text] [Related]
3. Karyopherin alpha 2 is a novel prognostic marker and a potential therapeutic target for colon cancer.
Zhang Y; Zhang M; Yu F; Lu S; Sun H; Tang H; Peng Z
J Exp Clin Cancer Res; 2015 Dec; 34():145. PubMed ID: 26626145
[TBL] [Abstract][Full Text] [Related]
4. Karyopherin α-2 is a reliable marker for identification of patients with high-risk stage II colorectal cancer.
Jeong D; Kim H; Ban S; Oh S; Ji S; Kim D; Ahn TS; Kim HJ; Bae SB; Kwon HY; Im J; Lee MS; Cho HD; Kim CJ; Baek MJ
J Cancer Res Clin Oncol; 2017 Dec; 143(12):2493-2503. PubMed ID: 28875407
[TBL] [Abstract][Full Text] [Related]
5. Nuclear karyopherin alpha2 expression predicts poor survival in patients with advanced breast cancer irrespective of treatment intensity.
Gluz O; Wild P; Meiler R; Diallo-Danebrock R; Ting E; Mohrmann S; Schuett G; Dahl E; Fuchs T; Herr A; Gaumann A; Frick M; Poremba C; Nitz UA; Hartmann A
Int J Cancer; 2008 Sep; 123(6):1433-8. PubMed ID: 18561322
[TBL] [Abstract][Full Text] [Related]
6. Low cytoplasmic and nuclear KPNA2 expression in radiotherapy-treated head and neck squamous cell cancer is associated with an adverse outcome.
Erben PB; Brunner K; Hecht M; Haderlein M; Büttner-Herold M; Agaimy A; Fietkau R; Hartmann A; Distel LV
Int J Clin Exp Pathol; 2015; 8(12):15814-24. PubMed ID: 26884852
[TBL] [Abstract][Full Text] [Related]
7. Nuclear karyopherin-α2 expression in primary lesions and metastatic lymph nodes was associated with poor prognosis and progression in gastric cancer.
Altan B; Yokobori T; Mochiki E; Ohno T; Ogata K; Ogawa A; Yanai M; Kobayashi T; Luvsandagva B; Asao T; Kuwano H
Carcinogenesis; 2013 Oct; 34(10):2314-21. PubMed ID: 23749771
[TBL] [Abstract][Full Text] [Related]
8. Correlation of human epidermal growth factor receptor protein expression and colorectal cancer.
Yang WJ; Shen XJ; Ma XX; Tan ZG; Song Y; Guo YT; Yuan M
World J Gastroenterol; 2015 Jul; 21(28):8687-96. PubMed ID: 26229411
[TBL] [Abstract][Full Text] [Related]
9. KPNA2 predicts long term survival in patients with anaplastic oligoastrocytomas.
Gousias K; Niehusmann P; Gielen G; Simon M; Boström J
J Clin Neurosci; 2014 Oct; 21(10):1719-24. PubMed ID: 24929863
[TBL] [Abstract][Full Text] [Related]
10. Association of overexpressed karyopherin alpha 2 with poor survival and its contribution to interleukin-1β-induced matrix metalloproteinase expression in oral cancer.
Wang CI; Yu CJ; Huang Y; Yi JS; Cheng HW; Kao HK; Lao WW; Chang KP
Head Neck; 2018 Aug; 40(8):1719-1733. PubMed ID: 29542209
[TBL] [Abstract][Full Text] [Related]
11. Expression of Karyopherin Alpha 2 and Karyopherin Beta 1 Correlate with Poor Prognosis in Gastric Cancer.
Ohhara Y; Kinoshita I; Suzuki A; Imagawa M; Taguchi J; Noguchi T; Takeuchi S; Shimizu Y; Seki H; Suzuki J; Dosaka-Akita H
Oncology; 2022; 100(12):685-695. PubMed ID: 36273446
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of karyopherin-2 in epithelial ovarian cancer and correlation with poor prognosis.
Zheng M; Tang L; Huang L; Ding H; Liao WT; Zeng MS; Wang HY
Obstet Gynecol; 2010 Oct; 116(4):884-891. PubMed ID: 20859152
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of increased KPNA2 expression in some solid tumors: A systematic review and meta-analysis.
Zhou LN; Tan Y; Li P; Zeng P; Chen MB; Tian Y; Zhu YQ
Oncotarget; 2017 Jan; 8(1):303-314. PubMed ID: 27974678
[TBL] [Abstract][Full Text] [Related]
14. Karyopherin alpha 2 expression is a novel diagnostic and prognostic factor for colorectal cancer.
Yu L; Wang G; Zhang Q; Gao L; Huang R; Chen Y; Tang Q; Liu J; Liu C; Wang H; Wang X
Oncol Lett; 2017 Mar; 13(3):1194-1200. PubMed ID: 28454233
[TBL] [Abstract][Full Text] [Related]
15. High expression of KPNA2 defines poor prognosis in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy.
Shi B; Su B; Fang D; Tang Y; Xiong G; Guo Z; He Q; Yang X; Zhao W; Guo Y; Li X; Zhou L
BMC Cancer; 2015 May; 15():380. PubMed ID: 25956057
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of karyopherin-α2 in cholangiocarcinoma correlates with poor prognosis and gemcitabine sensitivity via nuclear translocation of DNA repair proteins.
Tsukagoshi M; Araki K; Yokobori T; Altan B; Suzuki H; Kubo N; Watanabe A; Ishii N; Hosouchi Y; Nishiyama M; Shirabe K; Kuwano H
Oncotarget; 2017 Jun; 8(26):42159-42172. PubMed ID: 28178675
[TBL] [Abstract][Full Text] [Related]
17. KPNA2 expression is a potential marker for differential diagnosis between osteosarcomas and other malignant bone tumor mimics.
Jiang L; Liu J; Wei Q; Wang Y
Diagn Pathol; 2020 Nov; 15(1):135. PubMed ID: 33176814
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of karyopherin 2 in human ovarian malignant germ cell tumor correlates with poor prognosis.
He L; Ding H; Wang JH; Zhou Y; Li L; Yu YH; Huang L; Jia WH; Zeng M; Yun JP; Luo RZ; Zheng M
PLoS One; 2012; 7(9):e42992. PubMed ID: 22962582
[TBL] [Abstract][Full Text] [Related]
19. KPNA2 is a nuclear export protein that contributes to aberrant localisation of key proteins and poor prognosis of breast cancer.
Alshareeda AT; Negm OH; Green AR; Nolan CC; Tighe P; Albarakati N; Sultana R; Madhusudan S; Ellis IO; Rakha EA
Br J Cancer; 2015 Jun; 112(12):1929-37. PubMed ID: 25989275
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical detection of high-mobility group box 1 correlates with resistance of preoperative chemoradiotherapy for lower rectal cancer: a retrospective study.
Hongo K; Kazama S; Tsuno NH; Ishihara S; Sunami E; Kitayama J; Watanabe T
World J Surg Oncol; 2015 Jan; 13():7. PubMed ID: 25622595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]